Erika Carmel Ltd (BCUR) - Total Liabilities
Based on the latest financial reports, Erika Carmel Ltd (BCUR) has total liabilities worth ILA18.11 Million ILA (≈ $48.56K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Erika Carmel Ltd (BCUR) net asset momentum to track the company's year-over-year net asset growth rate.
Erika Carmel Ltd - Total Liabilities Trend (2019–2024)
This chart illustrates how Erika Carmel Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Erika Carmel Ltd to measure how efficiently the company converts operating cash flow to free cash.
Erika Carmel Ltd Competitors by Total Liabilities
The table below lists competitors of Erika Carmel Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Veganz Group AG
F:VEZ
|
Germany | €20.64 Million |
|
Fluicell AB
ST:FLUI
|
Sweden | Skr6.56 Million |
|
Ambica Agarbathies & Aroma industries Limited
NSE:AMBICAAGAR
|
India | Rs1.32 Billion |
|
IMMO BLOCKCHAIN EO 1
F:QT5
|
Germany | €7.02 Million |
|
Braster S.A.
WAR:BRA
|
Poland | zł23.68 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Erika Carmel Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Erika Carmel Ltd market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Erika Carmel Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Erika Carmel Ltd (2019–2024)
The table below shows the annual total liabilities of Erika Carmel Ltd from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA19.71 Million ≈ $52.84K |
-14.97% |
| 2023-12-31 | ILA23.18 Million ≈ $62.14K |
-9.87% |
| 2022-12-31 | ILA25.72 Million ≈ $68.95K |
-30.62% |
| 2021-12-31 | ILA37.07 Million ≈ $99.38K |
-4.31% |
| 2020-12-31 | ILA38.74 Million ≈ $103.86K |
+68.76% |
| 2019-12-31 | ILA22.95 Million ≈ $61.54K |
-- |
About Erika Carmel Ltd
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic probl… Read more